Prilosec OTC, Nexium Launches Fed “Shark Fin” Monopoly Plan, Suit Claims
This article was originally published in The Tan Sheet
Executive Summary
Elements of the Prilosec OTC launch, ranging from the drug's 14-day term of use to supply shortages during its time on the market, were part of a plan by AstraZeneca to interfere with generic competition for its prescription proton pump inhibitors, retailers allege in a lawsuit against the U.K. drug maker